Showing 10,741 - 10,760 results of 226,405 for search '(( a ((linear decrease) OR (a decrease)) ) OR ( a ((latest decrease) OR (larger decrease)) ))', query time: 1.62s Refine Results
  1. 10741
  2. 10742

    S1A Fig raw image. by Rachel K. Meade (22216529)

    Published 2025
    “…Here, we identify cathepsin Z (<i><i>Ctsz</i></i>) as a lead candidate underlying this TB susceptibility and show that <i><i>Ctsz</i></i> ablation leads to increased bacterial burden, pulmonary inflammation and decreased survival in mice. …”
  3. 10743

    Behavioural data from Study A. by Jasmine Heurlin (18501279)

    Published 2024
    “…In addition, human walking positively influenced eye contact behaviour while simultaneously decreasing exploration behaviour. In study C, a group of six socialised pack-living wolves and six similarly socialised pack-living dogs were tested after the <i>Ignore</i> treatment. …”
  4. 10744

    Establishment of a diabetic rat model. by Lan Zeng (638254)

    Published 2025
    “…In addition, RP11-502I4.3 expression was decreased in the retinas of diabetic rats compared with non-diabetic rats (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0312791#pone.0312791.g003" target="_blank">Fig 3B</a>), and it was predominantly localised in the cytoplasm (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0312791#pone.0312791.g003" target="_blank">Fig 3C</a>).…”
  5. 10745
  6. 10746

    S4 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  7. 10747

    S1 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  8. 10748

    S5 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  9. 10749

    S3 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  10. 10750

    S6 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  11. 10751

    Input parameters for the base-case analysis. by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  12. 10752

    S2 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  13. 10753

    S1 Data - by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  14. 10754
  15. 10755
  16. 10756
  17. 10757
  18. 10758
  19. 10759
  20. 10760